IC₅₀s data of antimalarials against controls. حسب Winnie Okore (14139712)

الموضوعات:

Drugs IC₅₀s data during the study period. حسب Winnie Okore (14139712)

الموضوعات:

SNPs IC₅₀s data at codon 876 during the study period. حسب Winnie Okore (14139712)

الموضوعات:

Association of polymorphic IC_50s versus wild<i>-</i>type at codon 876 in selected drugs tested. حسب Winnie Okore (14139712)

الموضوعات:

Detection of the Challenging mutations at 1% VAF and 50 ng DNA input. حسب Lizhi Yu (12476136)

Definitions of the features selected [50]. حسب Yu Zhang (12946)

Expression of ApoB-50 decreased lipid accumulation and inhibited HCV production. حسب Bei Wang (116772)

The decrease in blood flow disrupts CV pruning. حسب Lin Wen (557398)

Comparison of baseline characteristics stratified by the occurrence of ISR > 50%. حسب Jae-Chan Ryu (2850581)

Decrease in vRNA in brain during antiretroviral therapy. حسب Sonny R. Elizaldi (9684796)

Sensitivity analysis of 50:50 model. حسب Rachael Miller Neilan (10678614)

"…<p>A sensitivity analysis was conducted on the 50:50 model with constant 120 pA current to determine the sensitivity of pain output to select model parameters before injury (t = 10), during injury (t = 105), and after injury (t = 240). …"

Binary and ordinal logistic regression analysis of predictors for the occurrence of ISR > 50%. حسب Jae-Chan Ryu (2850581)

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations حسب Hui Li (32376)

الموضوعات:

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations حسب Hui Li (32376)

الموضوعات:

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations حسب Hui Li (32376)

الموضوعات:

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations حسب Hui Li (32376)

الموضوعات:

Primary endpoint analysis, i.e., time to first occurrence of combined event of 50% decrease in eGFR or ESRD. حسب Rozita Mohd (7411322)

Kylo-0603’s EC50 & tissue levels. حسب Xueqin lu (22250795)

Effect of melatonin (50 μM) on the TGF-β1 (10 ng/mL, 72 h)-mediated TGF-β1/Smad pathway and EMT in HBdSMCs. حسب Yang Zhang (30734)

ROC curve and P-R curve (attack traffic proportion = 50%). حسب Longyan Ran (18452261)